Delivery Order SPE2DB24D2205-SPE2DB25FDYYA

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Lyrica 225 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,462.32 and a period of performance through April 16, 2024. It is a firm-fixed-price delivery order contract, and there was no set-aside requirement. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora,...
This federal contract award is for the delivery of Lyrica 150 mg capsules to support the Defense Logistics Agency (DLA) Troop Support Medical program. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,347.23 and an ultimate completion date of August 23, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,534.05 firm fixed-price delivery order is for the supply of Lyrica 300 mg capsules. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is for the delivery of Lyrica 100 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,352.24, is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to supply a...
This federal contract award is for the delivery of Lyrica 75 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 23, 2024, with an ultimate completion date of October 24, 2024. The contract has a ceiling value of $1,777.74 and is a firm-fixed-price delivery order. This award is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of Lyrica 50 mg capsules to support the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type, valued at $1,616.22. It has an ultimate completion date of March 27, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of Lyrica 150 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,493.54 and an ultimate completion date of November 10, 2021. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award is for the delivery of Lyrica 75 mg capsules to the Defense Logistics Agency (DLA). The $9,849.11 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 20, 2024 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Lyrica 75 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 23, 2024. The contract has a ceiling value of $5,475.82 and is a firm fixed price delivery order. The contract is not designated as a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of a prescription medication, Lyrica 150 mg capsules. The contract has a ceiling value of $3,817.98 and a performance period ending on September 19, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDYYA
    Delivery Order

This federal contract award is for the delivery of Lyrica 300 mg capsules to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,387.32 and is a Firm Fixed Price Delivery Order. The awardee is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/28/25, 10:54 AM